Market Overview

Benzinga's Top Pre-Market Gainers

Related KORS
Wedbush On Retail Softline Channel Checks
Jefferies: Michael Kors' International Story Unappreciated
Making Money With Charles Payne: 12/11/14 (Fox Business)
Related BMRN
UPDATE: UBS Securities Reiterates On BioMarin Pharmaceutical On Path To Long-Term Upside
FDA Grants BioMarin Orphan Drug Designation for NAGLU Fusion Protein, BMN 250, for the Treatment of MPS IIIB

Michael Kors Holdings Ltd (NYSE: KORS) surged 13.41% to $43.30 in the pre-market session. Michael Kors reported a rise in its fourth-quarter profit.

BioMarin Pharmaceutical Inc (NASDAQ: BMRN) added 7.04% to $38.16 in the pre-market session. BMRN's trailing-twelve-month revenue is $448.55 million.

Arena Pharmaceuticals Inc (NASDAQ: ARNA) moved up 2.47% to $7.25 in the pre-market session. ARNA shares have surged 444.62% over the past 52 weeks, while the S&P 500 index has gained 1.64% in the same period.

Juniper Networks Inc (NYSE: JNPR) soared 2.13% to $16.75 in the pre-market trading. Juniper Networks approved a plan to buy back up to $1 billion of its own stock.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (ARNA + BMRN)

Around the Web, We're Loving...

Get Benzinga's Newsletters